Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Long-Term Investments (2021 - 2023)

Agilon Health (AGL) has disclosed Long-Term Investments for 3 consecutive years, with $5.1 million as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Long-Term Investments fell 28.86% year-over-year to $5.1 million, compared with a TTM value of $5.1 million through Mar 2023, down 28.86%, and an annual FY2022 reading of $4.7 million, down 27.01% over the prior year.
  • Long-Term Investments was $5.1 million for Q1 2023 at Agilon Health, up from $4.7 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $7.2 million in Q1 2022 and bottomed at $3.6 million in Q2 2022.
  • Average Long-Term Investments over 3 years is $5.6 million, with a median of $5.8 million recorded in 2021.
  • The sharpest move saw Long-Term Investments dropped 27.01% in 2022, then decreased 28.86% in 2023.
  • Year by year, Long-Term Investments stood at $6.4 million in 2021, then fell by 27.01% to $4.7 million in 2022, then rose by 10.5% to $5.1 million in 2023.
  • Business Quant data shows Long-Term Investments for AGL at $5.1 million in Q1 2023, $4.7 million in Q4 2022, and $6.4 million in Q3 2022.